2-bromo-5-methoxy-1,4-dihydropyridin-4-one, 97%, 5g

N-(4-Bromo-2-chlorophenyl)acetamide, 97.0%, 25g

(S)-3-(3-acetyl-4-hydroxyphenyl)-2-aminopropanoic acid hydrochloride, 98%, 100mg

6-Chloro-2H-1,4-benzoxazin-3(4H)-one, 95.0%, 1g

1,1-Cyclohexanediacetic acid, 95.0%, 100g

4-(4-fluorobenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

[4-(1-piperidinylcarbonyl)benzyl]amine hydrochloride, 95.0%, 1g

5-Aminothiazole-2-carboxylic acid hydrochloride, 95.0%, 250mg

HPLC column NUCLEODUR® NH2 5 µm, 150 mm, 4.6 mm, 1 Piece(s)

6-Aminocaproic acid, 98.0%, 25g

Diphenylacetylene>98.0%(GC)25g

2-Methyl-2-propanethiol, 95.0%, 1g

(2-(tert-Butoxy)pyridin-3-yl)boronic acid, 95.0%, 10g